BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3442460)

  • 1. [Toxic epidermal necrolysis in children (Lyell's syndrome). Apropos of 18 cases].
    Teillac D; Marsol P; Richard P; Hubert P; Roujeau JC; Cloup M; De Frost Y
    Arch Fr Pediatr; 1987 Oct; 44(8):583-7. PubMed ID: 3442460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Lyell's syndrome in children].
    Kushch NL; Iulish EI; Sushkov NT; Levin AG
    Khirurgiia (Mosk); 1984 Apr; (4):117-20. PubMed ID: 6737886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxic Epidermal Necrolysis (Lyell syndrome): a pathology for burn units].
    Cabral L; Diogo C; Riobom F; Teles L; Cruzeiro C
    Acta Med Port; 2004; 17(2):129-40. PubMed ID: 15921643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lyell's syndrome and ectodermosis pluriorificialis during treatment with oxicams: 11 cases].
    Guillaume JC; Roujeau JC; Chevais M; Albengres E; Revuz J; Touraine R
    Ann Dermatol Venereol; 1985; 112(10):807-12. PubMed ID: 4091406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular manifestations during Lyell's syndrome. Apropos of 3 cases appearing after use of sulfonamides].
    Saraux H; Chigot PL; Chassagne P; Devaux JP
    Bull Soc Ophtalmol Fr; 1965 Nov; 65(11):915-9. PubMed ID: 5866222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lyell's syndrome: a report of 16 cases].
    Boussofara L; Maalaoui H; Mebazaa A; Ghariani N; Denguezli M; Belajouza C; Nouira R
    Tunis Med; 2007 Sep; 85(9):801-5. PubMed ID: 18254315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lyell syndrome in Senegal: responsibility of thiacetazone].
    Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
    Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxic epidermal necrolysis, a life-threatening skin disease].
    Brouwer KJ; Boxma H; Dokter J
    Ned Tijdschr Geneeskd; 1994 Sep; 138(36):1819-22. PubMed ID: 7935909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).
    Guillaume JC; Roujeau JC; Revuz J; Penso D; Touraine R
    Arch Dermatol; 1987 Sep; 123(9):1166-70. PubMed ID: 3632001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lyell's syndrome with transient bone marrow depression caused by oxyphenebutazone].
    Zeile G; Wandel E; Bork K; Krönig B
    MMW Munch Med Wochenschr; 1979 Jul; 121(28):949-52. PubMed ID: 113668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ocular complications of Lyell's syndrome: recent concepts apropos of 26 cases].
    Binaghi M; Koso M; Roujeau JC; Coscas G
    J Fr Ophtalmol; 1985; 8(3):239-43. PubMed ID: 4056315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lyell's syndrome and its ophthalmologic manifestations in Cameroon].
    Moussala M; Beharcohen F; Dighiero P; Renard G
    J Fr Ophtalmol; 2000 Mar; 23(3):229-37. PubMed ID: 10740048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
    Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
    Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Lyell's syndrome].
    Badaev FI; Popov AA; Goloborodova GG; Beĭlina EV
    Ter Arkh; 1988; 60(8):114-6. PubMed ID: 3227476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxic epidermal necrolysis. Lyell's Syndrome].
    Kaczorowska-Hanke H; Piotrowski P; Hanke J
    Przegl Dermatol; 1966; 53(2):197-201. PubMed ID: 5947569
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visceral manifestations in toxic epidermal necrolysis (Lyell's syndrome)].
    Martovitskaia AA; Kozulin EA
    Klin Med (Mosk); 1983 Aug; 61(8):115-8. PubMed ID: 6689040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemosorption in the intensive treatment of Lyell's disease].
    Gonchar DI
    Anesteziol Reanimatol; 1983; (6):61-2. PubMed ID: 6670778
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage.
    Engelhardt SL; Schurr MJ; Helgerson RB
    J Burn Care Rehabil; 1997; 18(6):520-4. PubMed ID: 9404986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis in a child after carbamazepine dosage increment.
    Sevketoglu E; Hatipoglu S; Akman M; Bicer S
    Pediatr Emerg Care; 2009 Feb; 25(2):93-5. PubMed ID: 19225374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.